Mr. Chair, I believe it is the responsibility of the federal government as the regulator of a price regime in the country for prescription drugs and the approver of drugs. It is our role to make sure that we have the safety and supply of drugs for Canadians at the core of our program and our actions.
There are many options one can look at. The only option that I think at this time is viable and one which I am looking at is the option as I said earlier before the committee of looking at amending the definition of the term “practitioner” to see if we could prevent or deter members of the medical profession from providing prescriptions to people who are not residents of Canada and who are not visitors in Canada.